What is Intermediate Size Patient Population Expanded Access?
Intermediate size patient population expanded access refers to a program that allows groups of patients who are not eligible to participate in clinical trials to gain access to investigational drugs outside of these trials. This is particularly relevant in the context of cancer, where patients may have exhausted all available treatment options and are in urgent need of new therapies.
